Document is current
Any future updates will be listed below
-
Authors
Maehara, Kosuke
Esaki, Mitsuru
Sumida, Yorinobu
Yamaguchi, Daisuke
Nishioka, Kei
Homma, Hitoshi
Inada, Taisuke
Shiotsuki, Kazuo
Fukuda, Shin-Ichiro
Akiho, Hirotada
Nomura, Tadahiro
Mizuta, Yumi
Ishida, Satoshi
Fujimoto, Shun
Kimura, Shunichiro
Tanaka, Yuichiro
Hata, Kaori
Shiga, Noriko
Iwasa, Tsutomu
Kimura, Yusuke
Nakamura, Norimoto
Suzuki, Yusuke
Minoda, Yosuke
Hata, Yoshitaka
Ogino, Haruei
Tagawa, Koshiro
Ihara, Eikichi http://orcid.org/0000-0002-7070-6610
Ogawa, Yoshihiro
- License Information
-
More Information
Article History
Received: 18 August 2023
Accepted: 6 December 2023
First Online: 15 January 2024
Declarations
:
: The protocol of this trial has been designed in accordance with the SPIRIT guidelines and approved by the Kitakyushu City Hospital Organization IRB for Clinical Trials (No. 202203010) and the local IRBs of the participating sites. This trial will be conducted in accordance with the guidelines of the Declaration of Helsinki and Good Clinical Practice. Written informed consent will be obtained from all eligible patients prior to registration.
: Informed consent form is attached to the InternalRef removed.
: HO belongs to an endowed course supported by the companies mentioned, including Miyarisan Pharmaceutical Co. Ltd., Fujifilm Medical Co. Ltd., Terumo Corporation, Fancl Corporation, and Muta Hospital. EI received a lecture fee from Takeda Pharmaceutical Co, Ltd. The authors declare no conflicts of interest.
